Suppr超能文献

CTX-M-215 的进化,一种新型窄谱β-内酰胺酶,在一株对美西林耐药的大肠杆菌临床分离株中发现。

Evolution of CTX-M-215, a Novel Narrow-Spectrum β-Lactamase in an Escherichia coli Clinical Isolate Conferring Resistance to Mecillinam.

机构信息

Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.

Key Laboratory of Clinical Pharmacology of Antibiotics, National Heath Commission of the People's Republic of China, Shanghai, China.

出版信息

Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.00562-20.

Abstract

Here, we report a novel narrow-spectrum β-lactamase CTX-M-215 identified in an clinical isolate in China and conferring high-level resistance to mecillinam but not to cefotaxime. CTX-M-215 differed from CTX-M-125, a CTX-M extended-spectrum β-lactamase (ESBL), by an N132D substitution, which decreased hydrolytic activities toward penicillins and cephalosporins except for mecillinam. High similarity was observed between CTX-M-215- and CTX-M-125-bearing plasmids, carried by different isolates in the same patient, indicating evolution of CTX-M-215 from CTX-M-125.

摘要

在这里,我们报道了一种新型的窄谱β-内酰胺酶 CTX-M-215,它存在于中国的一株临床分离株中,对氨曲南具有高水平耐药性,但对头孢噻肟没有耐药性。CTX-M-215 与 CTX-M-125(CTX-M 型超广谱β-内酰胺酶)的区别在于 N132D 取代,这降低了除氨曲南以外的青霉素类和头孢菌素类药物的水解活性。在同一患者携带的不同分离株中,CTX-M-215 携带的质粒与 CTX-M-125 携带的质粒高度相似,表明 CTX-M-215 是由 CTX-M-125 进化而来的。

相似文献

2
CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
J Antimicrob Chemother. 2014 Aug;69(8):2081-5. doi: 10.1093/jac/dku126. Epub 2014 Apr 28.
3
Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
J Microbiol Immunol Infect. 2016 Oct;49(5):692-700. doi: 10.1016/j.jmii.2015.05.009. Epub 2015 Jun 27.
5
Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
J Appl Microbiol. 2005;98(4):921-7. doi: 10.1111/j.1365-2672.2004.02526.x.

引用本文的文献

1
Mecillinam activity against multidrug-resistant and .
Microbiol Spectr. 2025 Mar 4;13(3):e0100624. doi: 10.1128/spectrum.01006-24. Epub 2025 Feb 7.
2
Activity of mecillinam against carbapenem-resistant Enterobacterales.
J Antimicrob Chemother. 2022 Sep 30;77(10):2835-2839. doi: 10.1093/jac/dkac226.
3
High-Frequency Detection of and Genes in From Longitudinal Monitoring in Broiler Chicken Farms.
Front Microbiol. 2022 May 18;13:846116. doi: 10.3389/fmicb.2022.846116. eCollection 2022.

本文引用的文献

2
CTX-M-33, a CTX-M-15 derivative conferring reduced susceptibility to carbapenems.
Antimicrob Agents Chemother. 2019 Sep 9;63(12). doi: 10.1128/AAC.01515-19. Epub 2019 Sep 16.
3
Results from a Prospective Study on the Mecillinam (Amdinocillin) Susceptibility of .
Antimicrob Agents Chemother. 2019 Mar 27;63(4). doi: 10.1128/AAC.02402-18. Print 2019 Apr.
5
CTX-M-190, a Novel β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate.
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.01848-16. Print 2017 Jan.
6
Acquisition of Carbapenem Resistance by Plasmid-Encoded-AmpC-Expressing Escherichia coli.
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.01413-16. Print 2017 Jan.
7
8
Molecular basis for the catalytic specificity of the CTX-M extended-spectrum β-lactamases.
Biochemistry. 2015 Jan 20;54(2):447-57. doi: 10.1021/bi501195g. Epub 2014 Dec 24.
9
In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase.
J Antimicrob Chemother. 2014 Oct;69(10):2873-5. doi: 10.1093/jac/dku204. Epub 2014 Jun 10.
10
CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
J Antimicrob Chemother. 2014 Aug;69(8):2081-5. doi: 10.1093/jac/dku126. Epub 2014 Apr 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验